BACKGROUND Sarcopenia is a condition characterized by decreased skeletal muscle
mass due to physiological ageing or to a concomitant disease such as neoplasia. In cancer …

目的探索我国成年人主要慢性病与肌肉重量, 力量和质量的关系. 方法主要利用中国慢性病前瞻
性研究项目的第二次重复调查, 采用logistic 回归分析主要慢性病种类, 个数及患病年限与肌肉 …

Background An increased number of breast cancer patients are challenged by acute and
persistent treatment side effects. Oncology guidelines have been establishing physical …

Introduction Considering the high morbimortality rate in oncologic surgeries of the
gastrointestinal tract, especially in patients with malnutrition, the use of predictive tools is …

Introduction We investigated the associations among frailty, as determined via the
comprehensive geriatric assessment (CGA), muscle measures (ie, sarcopenia), and …

OBJECTIVES Depletion in skeletal muscle is closely associated with limited physical ability
and high mortality. In this study, we evaluated the prognostic significance of skeletal muscle …

Background There is emerging evidence that cancer and its treatments may accelerate the
normal aging process, increasing the magnitude and rate of decline in functional capacity …

Background: Rates of adverse events with sorafenib were higher in the DECISION trial in
radioactive iodine-refractory, advanced differentiated thyroid cancer (DTC) than in trials of …

Simple Summary Sarcopenia, ie, the loss of muscle mass is a risk factor for reduced survival
and increased treatment-associated toxicities in many cancers, and it increases with age. In …

The excitement about immunotherapy is justified. Patients with advanced disease and
limited life expectancy before immune checkpoint inhibitors are now having prolonged and …